Bone Mineral Density Changes Associated With Pregnancy, Lactation, and Medical Treatments in Premenopausal Women and Effects Later in Life

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

(2021) Ayman Al-Hendy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update

(2020) Dolores Shoback et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids

(2020) William D. Schlaff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial

(2020) Jacques Donnez et al.   FERTILITY AND STERILITY

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

(2020) James A. Simon et al.   OBSTETRICS AND GYNECOLOGY

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline

(2019) Richard Eastell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of breastfeeding, maternal anthropometry and body composition in women at 30 years of age

(2019) Natália Peixoto Lima et al.   Cadernos de Saude Publica

Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery

(2019) Jong-Wook Seo et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study

(2019) Thomas D’Hooghe et al.   HUMAN REPRODUCTION

Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos)

(2019) Sandra Cooke-Hubley et al.   Archives of Osteoporosis

Long-term outcome of patients with pregnancy and lactation-associated osteoporosis (PLO) with a particular focus on quality of life

(2019) Martin Gehlen et al.   CLINICAL RHEUMATOLOGY

Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk

(2019) Tina Raine-Bennett et al.   OBSTETRICS AND GYNECOLOGY

Short- and long-term impact of gonadotropin-releasing hormone analogue treatment on bone loss and fracture

(2019) May-Tal Sauerbrun-Cutler et al.   FERTILITY AND STERILITY

Screening for Osteoporosis to Prevent Fractures

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Postmenopausal Osteoporosis: A Clinical Review

(2018) Nelson B. Watts   JOURNAL OF WOMENS HEALTH

Long-Term Outcomes of Elagolix in Women With Endometriosis

(2018) Eric Surrey et al.   OBSTETRICS AND GYNECOLOGY

Drug-induced bone loss: a major safety concern in Europe

(2018) Khac-Dung Nguyen et al.   Expert Opinion On Drug Safety

Menstrual and reproductive factors and risk of vertebral fractures in Japanese women: the Japan Public Health Center-based prospective (JPHC) study

(2018) Y. Shimizu et al.   OSTEOPOROSIS INTERNATIONAL

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

(2018) Bruce R. Carr et al.   OBSTETRICS AND GYNECOLOGY

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

(2017) Hugh S. Taylor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Associations of Parity, Breastfeeding, and Fractures in the Womenʼs Health Observational Study

(2017) Carolyn J. Crandall et al.   OBSTETRICS AND GYNECOLOGY

Adverse bone effects of medications used to treat non-skeletal disorders

(2017) N. B. Watts   OSTEOPOROSIS INTERNATIONAL

Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise

(2017) N. Binkley et al.   OSTEOPOROSIS INTERNATIONAL

Bone metabolism during pregnancy

(2016) Jean Pierre Salles   ANNALES D ENDOCRINOLOGIE

Eating disorders, menstrual dysfunction, weight change and DMPA use predict bone density change in college-aged women

(2016) Jeri W. Nieves et al.   BONE

Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data

(2016) M. Bonafede et al.   Archives of Osteoporosis

Breastfeeding and maternal health outcomes: a systematic review and meta-analysis

(2015) Ranadip Chowdhury et al.   ACTA PAEDIATRICA

Parity, lactation, bone strength, and 16-year fracture risk in adult women: Findings from the Study of Women's Health Across the Nation (SWAN)

(2015) Takahiro Mori et al.   BONE

Presentation and management of osteoporosis presenting in association with pregnancy or lactation

(2015) C. S. Kovacs et al.   OSTEOPOROSIS INTERNATIONAL

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

(2015) Sanjay K. Agarwal et al.   Biomed Research International

Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis

(2014) Debin Wu et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review

(2014) Cherng-Jye Jeng et al.   EXPERT OPINION ON PHARMACOTHERAPY

Committee Opinion No. 602

(2014)   OBSTETRICS AND GYNECOLOGY

Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis

(2014) Bruce Carr et al.   Reproductive Sciences

Influence of number of deliveries and total breast-feeding time on bone mineral density in premenopausal and young postmenopausal women

(2013) Gloria Tsvetov et al.   MATURITAS

Use of Depot Medroxyprogesterone Acetate Contraception and Incidence of Bone Fracture

(2013) Lee L. Lanza et al.   OBSTETRICS AND GYNECOLOGY

Elagolix Treatment for Endometriosis-Associated Pain

(2013) Michael P. Diamond et al.   Reproductive Sciences

Breastfeeding protects against hip fracture in postmenopausal women: The Tromsø study

(2011) Åshild Bjørnerem et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women

(2011) Stephen Gehlbach et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture

(2011) Edward S. Leib et al.   JOURNAL OF CLINICAL DENSITOMETRY

Revised Reference Curves for Bone Mineral Content and Areal Bone Mineral Density According to Age and Sex for Black and Non-Black Children: Results of the Bone Mineral Density in Childhood Study

(2011) Babette S. Zemel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Forearm bone mineral density changes during postpartum and the effects of breastfeeding, amenorrhea, body mass index and contraceptive use

(2011) M. L. Costa et al.   OSTEOPOROSIS INTERNATIONAL

Use of Depot Medroxyprogesterone Acetate and Fracture Risk

(2010) Christian Meier et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Parity and risk of hip fracture in postmenopausal women

(2010) M. Kauppi et al.   OSTEOPOROSIS INTERNATIONAL

The effect of weight and weight change on the long-term precision of spine and hip DXA measurements

(2010) R. Rajamanohara et al.   OSTEOPOROSIS INTERNATIONAL

Maternal weight and lean body mass may influence the lactation-related bone changes in young undernourished Indian women

(2008) Bharati Kulkarni et al.   BRITISH JOURNAL OF NUTRITION

Racial differences in bone density and fracture risk in the United States

(2008) Marcella D. WALKER et al.   International Journal of Rheumatic Diseases